Barrette moves on from Yahoo!

Share this article:
Jack Barrette, formerly pharma category development officer for Yahoo!, has left the search engine to head up his own company. He is now CEO of MovingHealth, an online consumer health start-up. “We’re developing breakthrough user experiences in areas like rich media, video, user-generated content and social search,” Barrette said of his new company. “They are actively hiring a team with expertise in those areas both inside and outside of the healthcare industry.” Backed by venture capital firm General Catalyst, MovingHealth for the time being will be based at the VC’s Cambridge, Mass., offices. The new company doesn’t yet have a timeline for programs. Barrette said Yahoo! remains “dedicated to the healthcare and pharmaceutical space” and will look for a replacement for his position. Bonnie Becker, director, health category, Yahoo! Search Marketing, will assume Barrette’s duties in the meantime. Barrette, who joined Yahoo! in 2004, had been in charge of representing Yahoo! to the health and pharmaceutical industries and for advertising revenue derived from those industries.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...